Neurologically associated disability, such as Parkinson’s disease, Alzheimer’s disease (AD), and other cognitive losses, is due to defective cholinergic neurotransmission, caused by the lytic action of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) [2,3]. This evidence concerns the gene BCHE and Alzheimer disease.